Cramer’s lightning round: Cano Health is a buy

Cramer’s lightning round: Cano Health is a buy


Hasbro Inc: “I actually don’t even like the toy companies right now. … Let’s wait for now.”

Viatris Inc: “I don’t like those guys. I do think that [Johnson & Johnson] is going to spin off its consumer product company, and that’s going to be very, very good.”

IAC Inc: “That stock is so down. … Do I know that that stock has to bounce back? Yes. Do I know from what level? No. But I think you’re okay.”

Nike Inc: “I don’t think buying Nike here is that bad.”

Disclaimer: Cramer’s Charitable Trust owns shares of Johnson & Johnson.

Cramer's lightning round: Cano Health is a buy

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.



Source

The cost to fly private is up as much as 20% with fuel prices soaring
Business

The cost to fly private is up as much as 20% with fuel prices soaring

A Gulfstream G-IV private jet on approach to Washington’s Reagan National Airport in Arlington, Virginia, June 12, 2024. J. David Ake | Getty Images As the Iran war pushes jet fuel prices higher, well-heeled travelers are facing hefty surcharges to fly private, sometimes on flights booked months prior, charter brokers and aviation insiders told CNBC. […]

Read More
United unveils basic Polaris business fare in premium cabin overhaul
Business

United unveils basic Polaris business fare in premium cabin overhaul

United Airlines new Polaris seat on one of its Boeing 787 Dreamliners Leslie Josephs/CNBC Does it matter where you sit if you’re sipping Champagne in first class? United Airlines is betting that for some travelers looking for luxury at a discount, it doesn’t. The carrier is launching new, cheaper tiers for its top-end Polaris and […]

Read More
Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs
Business

Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs

The Trump administration is preparing to impose new tariffs on branded drugs from pharmaceutical companies that have not struck landmark deals with the president to lower their U.S. drug prices, CNBC has learned.  Patented medications and their active ingredients would be hit with a 100% tariff, according to a draft of the document obtained by […]

Read More